{"changes":[],"country":"GB","description":"Trogenix is a biotech company developing precision cancer gene therapies using its Odysseus platform and Synthetic Super-Enhancers that target cancer-specific transcription factors. It serves patients with aggressive solid tumors such as brain cancer. Its differentiator is combining cell killing, immune activation, and protection in one therapy.","domain":"trogenix.com","employees":null,"founded":2023,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":55.953346,"lng":-3.188375,"location":"Edinburgh, United Kingdom","name":"Trogenix","rounds":[{"amountQuarantined":false,"amountUsd":86400000,"currency":"EUR","date":"2025-10-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"series-a","url":null}],"slug":"trogenix-com","sources":[{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"trogenix.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://trogenix.com"},{"fact":"description","publisher":"trogenix.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://trogenix.com"}],"stage":"series-a","techStack":["Nginx","WordPress 7.0","Yoast SEO 27.6","Google Analytics","Google Tag Manager","Slider Revolution","jQuery Migrate 3.4.1","imagesLoaded 4.1.4","parallax.js","PHP","DoubleClick Floodlight","MySQL"],"totalRaisedUsd":102600000,"updatedAt":"2026-05-07"}